NM_005751.5(AKAP9):c.6176A>G (p.Glu2059Gly) AND Cardiovascular phenotype

Germline classification:: Likely benign (1 submission)
Last evaluated:: Dec 13, 2019
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000250867.5

Allele description [Variation Report for NM_005751.5(AKAP9):c.6176A>G (p.Glu2059Gly)]

NM_005751.5(AKAP9):c.6176A>G (p.Glu2059Gly)

Gene:

AKAP9:A-kinase anchoring protein 9 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

7q21.2

Genomic location:

Preferred name:

NM_005751.5(AKAP9):c.6176A>G (p.Glu2059Gly)

HGVS:

NC_000007.14:g.92065429A>G
NG_011623.1:g.129555A>G
NM_001379277.1:c.821A>G
NM_005751.5:c.6176A>GMANE SELECT
NM_147185.3:c.6176A>G
NP_001366206.1:p.Glu274Gly
NP_005742.4:p.Glu2059Gly
NP_005742.4:p.Glu2059Gly
NP_671714.1:p.Glu2059Gly
LRG_331t1:c.6176A>G
LRG_331:g.129555A>G
LRG_331p1:p.Glu2059Gly
NC_000007.13:g.91694743A>G
NM_005751.4:c.6176A>G

Protein change:

E2059G

Links:

dbSNP: rs73226383

NCBI 1000 Genomes Browser:

rs73226383

Molecular consequence:

NM_001379277.1:c.821A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_005751.5:c.6176A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_147185.3:c.6176A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Cardiovascular phenotype
Identifiers:: MedGen: CN230736

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000318922	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Likely benign (Dec 13, 2019)	germline	clinical testing	PubMed (2) [See all records that cite these PMIDs] 23861362, 25467552 Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000318922

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Likely benign
(Dec 13, 2019)

germline

clinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Interpreting secondary cardiac disease variants in an exome cohort.

Ng D, Johnston JJ, Teer JK, Singh LN, Peller LC, Wynter JS, Lewis KL, Cooper DN, Stenson PD, Mullikin JC, Biesecker LG; NIH Intramural Sequencing Center (NISC) Comparative Sequencing Program.

Circ Cardiovasc Genet. 2013 Aug;6(4):337-46. doi: 10.1161/CIRCGENETICS.113.000039. Epub 2013 Jul 16.

PubMed [citation]

PMID:: 23861362
PMCID:: PMC3887521

Next-generation sequencing of 34 genes in sudden unexplained death victims in forensics and in patients with channelopathic cardiac diseases.

Hertz CL, Christiansen SL, Ferrero-Miliani L, Fordyce SL, Dahl M, Holst AG, Ottesen GL, Frank-Hansen R, Bundgaard H, Morling N.

Int J Legal Med. 2015 Jul;129(4):793-800. doi: 10.1007/s00414-014-1105-y. Epub 2014 Dec 3.

PubMed [citation]

PMID:: 25467552

Details of each submission

From Ambry Genetics, SCV000318922.7

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (2)

Description

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Oct 20, 2024

ClinVar

Relating variation to medicine